Page 11 - Pharma Intelligence News Today

Breaking news headlines about Business Intelligence linking to 1,000s of websites from around the world

LONDON (dpa-AFX) - Informa (INF.L) has agreed to divest Pharma Intelligence to Warburg Pincus for 1.9 billion pounds. Following separation of Pharma intelligence, Informa will proceed with the

FTSE 100 up 0.2% ahead of US inflation figures

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Warburg Pincus has acquired Pharma Intelligence, a provider of specialist intelligence, data, and software for clinical trials, drug development and regulatory compliance, from Informa PLC.

Shares in the worlds largest exhibitions group rose as much as 5.4% to their highest level since November 2020 off the back of Thursdays announcement.

LONDON MARKET CLOSE: FTSE climbs but New York weaker after hot US CPI | Financial News

The potential demand for biosimilars undoubtedly generates an enormous opportunity for biopharmaceutical companies. However, biosimilar development and commercialiszation is an inimitably complex endeavour requiring a precise, stepwise strategy to ensure timely regulatory approval and optimum market access. Even companies that are aiming to protect the market share of a branded biologic product are compelled to adapt to the increased competition from biosimilars. Given these dynamics, the unique...

New report from Informa Pharma Intelligence finds Americans are closely watching COVID-19 vaccine and treatment clinical trials as the U.S. continues to...

Developing drugs can take almost $1 billion and works only 9% of the time. MIT professor Andrew Lo wants to change that.